US Patent Issued to AKASHA, LIV INNOVATION on July 15 for "Cannabigerol and pharmaceutical compositions comprising cannabigerol for use in the treatment of insomnia" (Swiss Inventor)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,357,585, issued on July 15, was assigned to AKASHA Corp. (Anguilla, Anguilla) and LIV INNOVATION SA (Lugano, Switzerland).

"Cannabigerol and pharmaceutical compositions comprising cannabigerol for use in the treatment of insomnia" was invented by Ronald Johannes Glas (Lugano, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to cannabigerol (CBG), a cannabinoid, for use in the treatment of chronic insomnia, sleeplessness and "staying in sleep" discomfort, subjective and objective sleep disorders, primary and secondary sleep disorders, insomnia related symptoms, depression, anxiety, and/or hyperactivity. The inventi...